Zobrazeno 1 - 10
of 73
pro vyhledávání: '"E. Estrabaud"'
Autor:
J. Eron, S. Little, G. Crofoot, P. Cook, P.J. Ruane, D. Jayaweera, E. DeJesus, S.E. Waldman, M.L. Mehrotra, L. VanderVeen, H. Huang, S. Collins, E. Estrabaud, J. Baeten, M. Caskey
Publikováno v:
Médecine et Maladies Infectieuses Formation. 2:S77
Autor:
Patrick Marcellin, E. Estrabaud
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 37
Autor:
Amir Guidoum, Armand Abergel, E. Estrabaud, Patrick Miailhes, Axelle SpampinatoMs, Philippe Sogni, Camille Liautard, Stéphanie Perot, Bertrand Hanslik, Denis Ouzan, Dan Pospait, Vincent Jouannaud, Jérémy Skrzypski, Jean-Pierre Bronowicki, Régine Truchi, Dominique Larrey
Publikováno v:
Journal of Hepatology. 70:e213
Autor:
S. De Muynck, Olivier Lada, E. Estrabaud, Cédric Laouénan, M. Lapalus, Pierre Bedossa, Michelle Martinot-Peignoux, Nathalie Boyer, Patrick Marcellin, Michel Vidaud, Q. Zhang, Tarik Asselah, Ivan Bièche, Rami Moucari
Publikováno v:
Journal of Viral Hepatitis. 21:525-532
The impact of IFNL3 (IL28B) polymorphism on response to interferon (IFN) treatment in patients infected with hepatitis B virus (HBV) is controversial. We aimed to investigate whether IFNL3 polymorphism (rs12979860) influences the long-term response o
Publikováno v:
Journal of Hepatology. 57:1110-1125
SummaryHCV infection is a global health problem that affects 170 million people worldwide. The severity of the disease varies from asymptomatic chronic infection to cirrhosis and hepatocellular carcinoma (HCC). Recently, the standard of care for geno
Autor:
Marie-Pierre Ripault, M. Lapalus, Michelle Martinot-Peignoux, Dominique Vidaud, Simon De Muynck, Julien Masliah-Planchon, Philippe Broët, E. Estrabaud, Ahmed El Ray, Ivan Bièche, Maud Blanluet, Nathalie Boyer, Michel Vidaud, Pierre Bedossa, Patrick Marcellin, Q. Zhang, Dominique Valla, Tarik Asselah, Olivier Lada
Publikováno v:
Journal of Hepatology. 56:527-532
Background & Aims Polymorphisms in the region of the interleukin ( IL ) 28B gene have been associated with pegylated-interferon (PEG-IFN) and ribavirin treatment response mainly in genotype 1 HCV infections. However, there are few data on HCV genotyp
Publikováno v:
Journal of Hepatology. 61:944-946
IFNL3, which encodes interferon-k3 (IFN-k3), has received considerable attention in the hepatitis C virus (HCV) field, as many independent genome-wide association studies have identified a strong association between polymorphisms near IFNL3 and clear
Autor:
M. Lapalus, E. Estrabaud, Patrick Marcellin, Simon De Muynck, Ivan Bièche, Tarik Asselah, David Saadoun, Michel Vidaud, Vassili Soumelis
Publikováno v:
Liver International. 30:1259-1269
Treatment for chronic hepatitis C virus (HCV) infection has evolved considerably in the last years. The standard of care (SOC) for HCV infection consists in the combination of pegylated interferon (PEG-IFN) plus ribavirin. However, it only induces a
Autor:
E. Estrabaud, Eric Quéméneur, Erwann Le Rouzic, Richard Benarous, Florence Margottin-Goguet, Laurent Daviet, Valérie Tanchou, Guillaume Blot, Irina Lassot
Publikováno v:
Cancer Research. 67:1054-1061
The Ras-association domain family 1 (RASSF1) gene has seven different isoforms; isoform A is a tumor-suppressor gene (RASSF1A). The promoter of RASSF1A is inactivated in many cancers, whereas the expression of another major isoform, RASSF1C, is not a
Autor:
E. Estrabaud, Erwann Le Rouzic, Jean-Christophe Rain, Catherine Transy, Nadia Belaïdouni, Marina Morel, Florence Margottin-Goguet
Publikováno v:
Cell Cycle. 6:182-188
How the HIV1 Vpr protein initiates the host cell response leading to cell cycle arrest in G(2) has remained unknown. Here, we show that recruitment of DCAF1/VprBP by Vpr is essential for its cytostatic activity, which can be abolished either by singl